G
G.C. Sturniolo
Researcher at University of Padua
Publications - 72
Citations - 3896
G.C. Sturniolo is an academic researcher from University of Padua. The author has contributed to research in topics: Inflammatory bowel disease & Ulcerative colitis. The author has an hindex of 28, co-authored 71 publications receiving 3443 citations. Previous affiliations of G.C. Sturniolo include University of Rome Tor Vergata.
Papers
More filters
Journal Article
Irritable bowel syndrome
Journal ArticleDOI
Intestinal permeability test as a predictor of clinical course in Crohn’s disease
Renata D'Incà,V. Di Leo,G Corrao,Diego Martines,Anna D'Odorico,C Mestriner,C. Venturi,G. Longo,G.C. Sturniolo +8 more
TL;DR: The L/M test identifies Crohn's disease patients in apparent remission, but with a high risk of clinical relapse, better than clinical and biochemical indices.
Journal ArticleDOI
Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease.
Anna D'Odorico,S. Bortolan,Romilda Cardin,Renata D'Incà,Diego Martines,Antonio Ferronato,G.C. Sturniolo +6 more
TL;DR: Depletion of antioxidants is likely to be important in the pathophysiology of IBD: UC and CD patients show increased free radical peripheral leukocyte DNA damage and decreased plasma antioxidant defenses.
Journal ArticleDOI
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease
Nicholas T. Ventham,Nicholas A. Kennedy,Alex Adams,Rahul Kalla,Simon Heath,KR O’Leary,Hazel E. Drummond,Gordan Lauc,Harry Campbell,Dermot P.B. McGovern,Vito Annese,Vlatka Zoldoš,Iain K. Permberton,Manfred Wuhrer,Manfred Wuhrer,Daniel Kolarich,Daryl L. Fernandes,Evropi Theorodorou,Victoria Merrick,Daniel I. R. Spencer,Richard A. Gardner,Ray Doran,Archana Shubhakar,Ray Boyapati,Igor Rudan,Paolo Lionetti,Irena Trbojević Akmačić,Jasminka Krištić,Frano Vučković,Jerko Štambuk,Mislav Novokmet,Maja Pučić-Baković,Olga Gornik,Angelo Andriulli,Laura Cantoro,G.C. Sturniolo,Gionata Fiorino,Natalia Manetti,Anna Latiano,Anna Kohn,Renata D'Incà,Silvio Danese,Ian D. Arnott,Colin L. Noble,Charlie W. Lees,Alan G. Shand,Gwo-Tzer Ho,Malcolm G. Dunlop,Lee Murphy,Jude Gibson,Louise Evenden,Nicola Wrobel,Tamara Gilchrist,Angie Fawkes,Guinevere S. M. Kammeijer,Florent Clerc,Noortje de Haan,Aleksandar Vojta,Ivana Samaržija,Dora Markulin,Marija Klasić,Paula Dobrinić,Yurii S. Aulchenko,Tim van den Heuve,Daisy Jonkers,Marieke Pierik,Simen Vatn,Petr Ricanek,Jørgen Jahnsen,Panpan You,Janne Sølvernes,Anna B. Frengen,Tone Møller Tannæs,Aina Elisabeth Fossum Moen,Fredrik A. Dahl,Jonas Christoffer Lindstrøm,Gunn S. Ekeland,Trond Espen Detlie,Åsa V. Keita,Johan D. Söderholm,Henrik Hjortswang,Jonas Halfvarson,Daniel Bergemalm,Fernando Gomollón,Mauro D'Amato,Leif Törkvist,Fredrik Hjelm,Mats Gullberg,Niklas Nordberg,Anette Ocklind,Erik Pettersson,Daniel Ekman,Mikael Sundell,Eddie Modig,Anne Clémence Veillard,Renaud Schoemans,Dominique Poncelet,Céline Sabatel,Marta Gut,Monica Bayes,C. Casén,Torbjørn Lindahl,Ewa Ciemniejewska,Morten H. Vatn,David C. Wilson,Ivo Gut,Elaine R. Nimmo,Jack Satsangi +107 more
TL;DR: Site-specific DNA methylation changes in IBD relate to underlying genotype and associate with cell-specific alteration in gene expression, andSeparated cell data shows that IBD-associated hypermethylation within the TXK promoter region negatively correlates with gene expression in whole-blood and CD8+ T cells, but not other cell types.
Journal ArticleDOI
Risk factors for non-adherence to medication in inflammatory bowel disease patients.
TL;DR: This study highlights the need to understand more fully the rationale behind the continued use of these drugs, as well as the individual’s individual needs, before and during treatment.